Navin K. Chintala

A Phase I Trial of Regional Mesothelin-Targeted CAR T-cell Therapy in Patients with Malignant Pleural Disease, in Combination with the Anti–PD-1 Agent Pembrolizumab

Prasad S. Adusumilli, Marjorie G. Zauderer, Isabelle Rivière et al. · Cancer Discovery · 2021 · 514 citations · Full text

Complement C5a Receptor Facilitates Cancer Metastasis by Altering T-Cell Responses in the Metastatic Niche

Surya Kumari Vadrevu, Navin K. Chintala, Sharad Sharma et al. · Cancer Research · 2014 · 188 citations

Pulmonary Alveolar Macrophages Contribute to the Premetastatic Niche by Suppressing Antitumor T Cell Responses in the Lungs

Sharad Sharma, Navin K. Chintala, Surya Kumari Vadrevu et al. · The Journal of Immunology · 2015 · 186 citations

Inflammatory Lung Disease, Lung Inflammation, Immunology +26

Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent.

Prasad S. Adusumilli, Marjorie G. Zauderer, Valerie W. Rusch et al. · Journal of Clinical Oncology · 2019 · 90 citations

Cell Therapy, Immunology, Immunoediting +21

The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1

Maciej M. Markiewski, Surya Kumari Vadrevu, Sharad Sharma et al. · The Journal of Immunology · 2017 · 78 citations · Full text